3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
HER2-positive Breast Cancer
6
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Salivary Gland Neoplasms
1
Rare Tumor
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-positive Advanced Breast Cancer
1
HER2-expressing Advanced Solid Tumors
1
HER2 Positive Breast Cancer
1
HER2 Insertion Mutation Positive Advanced NSCLC
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasm Female
1
Breast Cancer Metastatic
1
Breast Cancer Invasive
1
Breast Cancer Female
1
Advanced Breast Cancer
1
Interventions
pyrotinib
1
Neoadjuvant Therapy
1
Mastectomy, Modified Radical
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Locally Advanced Breast Cancer
×
pyrotinib
×
Clear all
NCT04254263
2025-09-11
ATP
RenJi Hospital
Phase 3
Recruiting
316 enrolled